# clm_CA9105114287

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: research_and_development  
value: 806,185,000 United States dollar  
valid_from: 2012-12-31  
valid_to: 2013-12-31  
published: 2013-03-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_727E384A5333  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals research and development: 806,185,000 United States dollar", as of 2012-12-31 (until 2013-12-31). Claim clm_CA9105114287, https://asof.is/claim/clm_CA9105114287, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532013000009/0000875320-13-000009-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2012, filed 2013-03-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532013000009/0000875320-13-000009-index.htm (primary, SEC EDGAR 10-K FY2012, published 2013-03-01)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | research_and_development | 707,706,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_CA9105114287](/claim/clm_CA9105114287.md) | [clm_7FB96A1EC04F](/claim/clm_7FB96A1EC04F.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.